Agreement with Baxter

Advanced Medical Solutions Grp PLC
03 May 2005


For Immediate Release                                         3 May 2005



                      Advanced Medical Solutions Group plc
                            ('AMS' or 'the Company')


Announces partner for marketing and distribution of its LiquiBandTM range
                            in France and Spain


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global
woundcare technology company, today announces that it has signed an exclusive
agreement with the Bio Surgery division of  Baxter Healthcare Europe for the
marketing and distribution of its LiquiBandTM tissue adhesive range in France
and Spain.


Based on cyanoacrylate (super-glue) technology, LiquiBandTM is a tissue adhesive
that is used to close wounds as an alternative to sutures, staples and adhesive
strips.  The global wound closure market is valued at $5 billion of which tissue
adhesives are estimated to make up around $100 million.  LiquiBandTM is market
leader in the UK Accident and Emergency arena. A product aimed specifically at
closing surgical incisions in the operating room, LiquiBand SurgicalTM, was
launched in 2004.  The LiquiBandTM and LiquiBand SurgicalTM product range has
already been introduced in many countries in Europe and AMS had been actively
seeking a partner for the major markets of France and Spain.


Commenting on today's announcement, Dr. Don Evans, Chief Executive of AMS, said:


'I am delighted that we have been able to find a strong partner to take our
LiquiBandTM range into the key strategic markets of France and Spain.  We now
have a broad partner base and look forward to replicating our success in the UK
throughout Europe.'


                                    - ENDS -


For further information, please contact:


Advanced Medical Solutions Group plc            Tel : [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com


Buchanan Communications                         Tel: [phone]
Mark Court, Mary-Jane Johnson



Notes to Editors:


Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $15 billion global woundcare market.


Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.


In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.


The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives that offer benefits over sutures and
staples for closing wounds sold direct to hospitals or through distributors.


AMS's technology and products currently serve the majority of the key global
markets with strategic partners including 3M, Novartis, Johnson & Johnson,
Molnlycke Healthcare, Smith + Nephew and Cardinal Health.








                      This information is provided by RNS
            The company news service from the London Stock Exchange